AD-214
Fibrotic diseases (IPF, kidney fibrosis)
Phase 2Active
Key Facts
About AdAlta
Australian biotech delivering CAR‑T and i‑body therapies for solid tumours, fibrosis and malaria.
View full company profileFibrotic diseases (IPF, kidney fibrosis)
Australian biotech delivering CAR‑T and i‑body therapies for solid tumours, fibrosis and malaria.
View full company profile